This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
12/01/15 - 3:59:57 PM ET (BATS BZX Real-time Price)
Div Yield: --
RVNC Day's Range
RVNC 52 Week Range
RVNC Business Summary
Revance Therapeutics, Inc., a clinical-stage specialty biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel botulinum toxin products for various aesthetic and therapeutic indications.View RVNC key stats
Revance Therapeutics Inc - RVNC - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Revance Therapeutics Inc as a
Sell with a ratings score of D.
Report Snippet: We rate REVANCE THERAPEUTICS INC (RVNC) a SELL. This is driven by a number of negative factors, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity and weak operating cash flow.